1. Home
  2. HUN vs ANIP Comparison

HUN vs ANIP Comparison

Compare HUN & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Huntsman Corporation

HUN

Huntsman Corporation

HOLD

Current Price

$11.73

Market Cap

2.0B

Sector

Industrials

ML Signal

HOLD

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$75.62

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HUN
ANIP
Founded
1970
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.0B
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
HUN
ANIP
Price
$11.73
$75.62
Analyst Decision
Hold
Strong Buy
Analyst Count
11
6
Target Price
$10.23
$105.83
AVG Volume (30 Days)
4.2M
462.3K
Earning Date
02-17-2026
02-27-2026
Dividend Yield
2.99%
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.67
Revenue
$5,780,000,000.00
$826,880,000.00
Revenue This Year
N/A
$44.06
Revenue Next Year
$3.31
$9.06
P/E Ratio
N/A
$45.54
Revenue Growth
N/A
48.87
52 Week Low
$7.30
$52.74
52 Week High
$18.53
$99.50

Technical Indicators

Market Signals
Indicator
HUN
ANIP
Relative Strength Index (RSI) 73.03 34.94
Support Level $9.90 $76.69
Resistance Level $11.32 $80.29
Average True Range (ATR) 0.45 2.79
MACD 0.11 -0.14
Stochastic Oscillator 94.96 7.87

Price Performance

Historical Comparison
HUN
ANIP

About HUN Huntsman Corporation

Huntsman Corp is a USA-based manufacturer of differentiated organic chemical products. Its product portfolio comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, among others. Its operating segments are Polyurethanes, Performance Products, and Materials. It derives the majority of its revenue from the Polyurethanes segment, which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States & Canada, Europe, Asia-Pacific, and the Rest of the world.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Share on Social Networks: